Skip to content

Clinical trials

Cognitive Dysfunction trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Country / region: Switzerland Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20113
20132
20143
20152
20161
20175
20184
20193
20205
20216
20222
20239
20244
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Recruiting10
Unknown status8
Not yet recruiting4
Terminated4
Active, not recruiting3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Bern9
University Hospital, Basel, Switzerland6
University of Zurich6
Insel Gruppe AG, University Hospital Bern3
Cantonal Hospital of St. Gallen2
Lucie Bréchet2
Andreas Monsch1
Biogem s.c.ar.l.1
Boris Quednow1
Bottneuro AG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction57
Alzheimer Disease16
Cognition Disorders4
Dementia4
Multiple Sclerosis4
Parkinson Disease4
Memory Disorders3
Nerve Degeneration3
Neurocognitive Disorders3
Fatigue2

Trials

Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.